Urogen Pharma Ltd

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$18.17

+0.51 (+2.89%)

As of Mar 25, 2:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +149.6% upside

Low Target $37.53

Average Target $45.36

High Target $61.85

Current Price $18.17

Current
$18.17

Target
$45.36

$37.53 $45.36 avg $61.85

Scenario Analysis

Bear Case

$37.53

106.5%

Low target

Base Case

$45.36

+149.6%

Avg target

Bull Case

$61.85

+240.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$30.00

-39.4% from high

52-Week Low

$3.42

+431.3% from low

Target vs 52W High

$45.36

+51.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%